La clave...

Tener diabetes no tiene que ser tan complicado como para tomar una actitud negativa, con solo pasarla lo más sano que se pueda y con una orientación adecuada, usted no tendrá que vivir para la diabetes sino vivir con la diabetes...

viernes, 20 de diciembre de 2013

lunes, 25 de noviembre de 2013

jueves, 21 de noviembre de 2013

Actualizándonos en el congreso de la ASOCIACIÓN LATINOAMERICANA DE DIABETES México noviembre 2013


lunes, 28 de octubre de 2013

El ka’a he’ê es una droga que puede combatir la diabetes y la hipertensión

Las investigaciones sobre el ka’a he’ê del Dr. Barriocanal ahora se vieron coronadas con la noticia reciente de la aceptación de la Stevia como edulcorante por la JECFA, el Comité de Estudios y Aditivos Alimentarios como máxima autoridad mundial en la materia. Sobre este tema nos explayamos en esta entrevista: -¿Ud. mantiene una estrecha relación con la Stevia? -Así es, tenemos una experiencia previa con colegas de Dinamarca en la cual hicimos el primer estudio en el mundo a largo plazo para personas con diabetes de Tipo II o no insulinodependientes. Para ello usamos un derivado de la Stevia para investigar sus efectos como medicamento para combatir la diabetes. -¿Y qué descubrieron? -Demostramos, tal como se publicó en el Congreso Europeo de Diabetes del 2005, que el steviósido, uno de los componentes de la planta de la Stevia, puede reemplazar a otros hipoglucemiantes orales, es decir, a otras pastillas para tratar la diabetes, quizás de manera más natural. Completo:

domingo, 20 de octubre de 2013

El efecto Tom Hanks: Cambio de actitud ante el diagnóstico de diabetes tipo 2

Tom Hanks performed an important role in raising awareness that any "regular guy" can develop type 2 diabetes when he went public with his diagnosis this week during several media interviews to promote his new movie, endocrinologists say.
Among the celebrity's appearances were a slot on CBS's The Late Show with David Letterman in the United States, where he first revealed the diagnosis, and an interview with the BBC in London.
"With Tom Hanks…you see someone who's not particularly overweight, who doesn't appear to lead an unhealthy lifestyle, and I think it's a very important message that anybody can develop diabetes, [and] that we remove the social stigma associated with it," Robert E. Ratner, MD, chief scientific and medical officer of the American Diabetes Association, told Medscape Medical News.
Diabetes is a very treatable disease with good guidelines for effective treatment, he stressed.
Tom Hanks
Anne Peters, MD, from the University of Southern California, echoes this view. "Tom Hanks is probably the most regular guy in the world of successful celebrities," she observes. "Basically, he said, ''We can all get this, so let's all be aware,' and he talked…about having been aware of [prediabetes] for a long time and having been involved in trying to be healthier," she noted.
Hanks, who is 57 and does not fit the stereotype of an overweight couch potato, told Letterman that he had had high-normal blood glucose for the past 20 years. But recently, his doctor informed him he had crossed the line from prediabetes to diabetes.
"I went to the doctor, [who said], 'You know, those high blood-sugar numbers you've been dealing with since you were 36? Well, you've graduated! You've got type 2 diabetes, young man," Hanks said on The Late Show. In other interviews, the actor added that he gets regular exercise, eats right, takes certain medications, and, so far, feels fine.
Positive Effects From Positive Celebrity Role Models
Dr. Peters says that by revealing that he has diabetes and is coping well, Tom Hanks has provided a very positive role model, with some of her patients telling her this week that they felt a bit better about having diabetes after hearing the news.
When celebrities like Hanks disclose that they have a disease, it can have a big impact, generating important discussions, she said, noting that this is what happened recently when Angelina Jolie revealed her decision to undergo a preventive mastectomy.
In the same way that Hollywood helped take away the glamour of cigarette smoking, it can perhaps contribute to increased awareness of prediabetes and diabetes, Dr. Peters hopes.
Several other well-known American personalities have also previously revealed they have diabetes, she noted. Actress Halle Berry presents a strong image of someone with type 2 diabetes, as does talk show host Larry King. And chef Paula Deen — despite the controversy surrounding her — "touched a lot of people in the South" when she revealed she had type 2 diabetes, notes Dr. Peters.
"People are going to listen to her more than me. I'm not famous. I'm just a doctor," she quipped.
Meanwhile, Mary Tyler Moore has championed type 1 diabetes, says Dr. Ratner, who reflected on her admirable ability to raise awareness of this disease as well as money to support diabetes research.
Other famous US names who have revealed they have type 1 diabetes include Chicago Bears quarterback Jay Cutler, singer Nick Jonas, and Bret Michaels, vocalist from the rock band Poison, who pledged his $250,000 winnings from TV's Celebrity Apprentice to the American Diabetes Association.
"If we can use [Tom Hanks's disclosure] as a moment for education and awareness, that's positive," said Dr. Ratner.
But Are There Also Unintended Consequences?
There are also potential downsides to these types of medical disclosures if a celebrity is a poor role model, however, said Dr. Peters.
"You don't want to have pictures of Tom Hanks with his type 2 diabetes smoking cigarettes and eating potato chips," she said, although she added quickly that this is unlikely, noting, "The worst…he ate [was] a box of chocolates in Forrest Gump."
And poorly informed celebrities might also spread misinformation, which was not the case with Hanks, she was keen to stress.
However, some media reports did mention that Hanks had gained and lost extreme amounts of weight for different film roles over the years and implied that this could have contributed to the diabetes, which is misleading, said Dr. Ratner.
"There is no question that in individuals who are at risk for developing diabetes, weight gain is something that can tip you over," he observed.
However, "there is no good evidence that weight cycling — gaining weight, losing weight — has a long-term effect on your risk of diabetes," he stressed.
Bottom Line: Celebrity Draws Attention to a Common Disease
The US Center for Disease Control currently estimates that 26 million people in the United States have diabetes (type 1 or type 2) — including 6 to 7 million people who don't know they have it — and about 79 million people have prediabetes.
Studies such as the Diabetes Prevention Program, STOP-NIDDM, DREAM, and ACT NOW have shown that lifestyle changes and pharmaceutical therapy can significantly reduce the development of diabetes in patients with prediabetes, Dr. Ratner noted.
"It is unfortunate that it takes a celebrity to bring attention to a disease that's affecting 26 million," he commented.
"Having said that, I commend [Tom Hanks] for his frankness and hope that we can utilize his public statement to help educate clinicians as well as patients about the risks of diabetes, the importance of making the diagnosis, and appropriate therapy," he concluded.
Dr. Peters is on the advisory board of Medscape Diabetes & Endocrinology

lunes, 29 de abril de 2013


martes, 16 de abril de 2013

Aumentando nuestro conocimiento con los maestros en Buenos Aires, Abr 2013

Todo médico debe obligatoriamente continuar en búsqueda de nuevo conocimiento, en medicina siempre hay algo por aprender !!! 


sábado, 6 de abril de 2013

CORRER O CAMINAR, cuàl es mejor o suficiente ?

Realmente està plenamente demostrado que el beneficio es el mismo !!!

Lo que vale es la cantidad no el tipo de ejercicio,el detalle es que correr equivale a màs ejercicio en menor tiempo, pero caminar es màs fàcil y sostenible para la mayorìa de las personas.
Envuelve los mismos grupos de mùsculos.


viernes, 15 de marzo de 2013

domingo, 24 de febrero de 2013

Nuevo medidor de glucosa para smartphone !!!

By: Brian Dolan | May 2, 2012 539 1372 336

Tags: | | | | | | |
iBGStar Diabetes Manager App iPhoneIn recent years Apple stores began selling fitness devices other than those offered by long time partner Nike+. The company also added Withings’ WiFi-enabled scale to its store shelves. Soon followed iHealth’s iOS Blood Pressure Monitor dock and more. This week Cupertino’s retail stores have begun selling Sanofi’s iBGStar device, the first FDA cleared iPhone-enabled blood glucose meter. MobiHealthNews learned about the launch during an on-site meeting at Sanofi headquarters in Bridgewater, New Jersey this week.
MobiHealthNews first reported on the iBGStar back in September 2010 when Sanofi and its partner device maker AgaMatrix released the first images of the device, which was also known as AgaMatrix’s Nugget device.
While the devices may still be making their way to some brick-and-mortar locations — Sanofi expects them to be in the stores by May 15 — Apple’s online store and are already selling the device. Apple is offering the iBGStar for about $100 while Walgreens has priced it at about $75. (An iPhone or iPod touch is not included, of course, and while the meter works without the device, much of its value would be lost without one.) Since Apple will not be selling testing strips for the device, its iBGStar package includes 50 strips, which explains the higher price. Walgreens’ iBGStar package includes just 10 strips, but additional strips can be purchased at Walgreens or from the store’s website. Sanofi says the prices work out to be about the same.
While Walgreens has an exclusive arrangement with Sanofi to sell the device and strips, Sanofi’s Shawna Gvazdauskas, VP and Device Head for US Diabetes, said that any pharmacist can order the device for a patient through McKesson.
Sanofi’s iBGStar is tiny. Some of the other bloggers and diabetes community leaders that attended Sanofi’s demo day this week noted that the device’s size alone is an impressive feature.
The device’s companion app, called iBGStar Diabetes Manager App, launched on Apple’s AppStore early last month. The app helps users analyze their glucose patterns over time, track eating and other activities that may have influenced their levels, and email data to care providers or others. The collected information is also displayed as scorecards that show individual test results in different colors that are coded to indicate high, low and within range blood glucose results. Readings from the iBGStar device are automatically loaded into the app when synched, and those readings are “locked” in — users are not able to edit them. Those readings also are indicated by a lock symbol on the corner of their scorecard, while any manually entered readings are marked with an “x” to indicate that they are editable and were manually entered. Sanofi expects that information to help care providers who might like to know which readings came from the device and were not edited.
Sanofi acknowledged that it is targeting a very specific group with an iPhone or iPod touch-based glucose meter. The company believes the number of potential users is about 1.6 million in the United States. When Sanofi first partnered with AgaMatrix to develop the device back in March 2010, AT&T had an exclusive for the iPhone. Once Verizon Wireless began offering the iPhone and — more recently — Sprint, Sanofi saw its potential iBGStar user base rise considerably.
iBGStar Diabetes Manager AppSanofi also said that Apple is excited about the iBGStar device. Apple included the iBGStar device in a recent “healthcare enterprise” roadshow for medical professionals. The presentation featured just three iOS-enabled devices and apps, according to Sanofi. One featured device was Withings’ WiFi-enabled weight scale. Two of them were Sanofi offerings: the iBGStar and the company’s GoMeals app, a nutrition tracking app for people with diabetes. Sanofi says the app, which launched in late 2009, now has 400,000 downloads. Apple suggested that Sanofi find ways to integrate the GoMeals app with the iBGStar Diabetes Manager app, according to the company, and it plans to do so.
While the current iteration of Sanofi iBGStar Diabetes Manager app does not include any automated coaching like WellDoc’s DiabetesManager program, Sanofi’s Gvazdauskas said that the two companies are already exploring ways to collaborate. No firm plans for a partnership have been officially announced yet, however. Adding services is an important next step of Sanofi’s three-prong diabetes franchise strategy, which includes “molecules”, devices, and services. The company is likely to offer some kind of discount or incentive to buy the iBGStar device to those who also use its diabetes drugs. While this is its first device, Sanofi expects to develop others.
Another wireless-enabled blood glucose device came up during the discussion at Sanofi’s event this week: Telcare. Telcare’s BGM was the first FDA-cleared cellular-enabled blood glucose meter. Sanofi’s Gvazdauskas said she was impressed with that company’s cloud-based platform and saw an opportunity to partner with Telcare to leverage its platform in the future.
Given the amount of press the iBGStar has already received pre-launch, Gvazdauskas said that Sanofi has already heard from a number of very interested customers. Self-insured employers, she said, were one group that seemed especially interested. Healthcare providers are eager to leverage iBGStar to track patients post-discharge to determine if, for example, the patient is being compliant with their treatment plan to test a certain number of times a day.
So what took so long? MobiHealthNews and others have been writing about the iBGStar for years. Gvazdauskas said the device entered the FDA’s regulatory machine when the agency was adding new requirements for medical device clearance — including new infection control policies — that slowed the process down. Gvazdauskas also said that her team has been asked many times why it has taken so long to commercially launch the device after securing FDA clearance last December.
She said Sanofi waited because it wanted to ensure there was adequate shelf space available to meet the demand.

viernes, 22 de febrero de 2013

QUINUA: El legado ancestral de los andinos para paliar la crisis alimentaria mundial !!!

Evo Morales lanza Año de la Quinua en la ONU

El presidente de Bolivia, Evo Morales, lanzó este miércoles en la sede de la ONU en Nueva York el Año Internacional de la Quinua, defendiendo el valor de este grano ancestral para combatir las crisis alimentarias y denunciando el boicot de las multinacionales a su desarrollo.

NUEVA YORK.- Morales fue la estrella de la ceremonia en la que estuvieron presentes la primera dama de Perú, Nadine Heredia; el secretario general de la ONU, Ban Ki-moon; ministros de Ecuador y Perú; y el director de la FAO (organización de Naciones Unidas para la Alimentación y la Agricultura) , José Graziano da Silva.

“La quinua es un legado ancestral de los pueblos andinos que se produce hace más de 7.000 años y que se presenta como una alternativa digna a la actual crisis alimentaria” , recordó el presidente boliviano en el hemiciclo de la ONU.

La declaración del año internacional “es el reconocimiento al conocimiento de las prácticas tradicionales de los pueblos indígenas de los Andes, que en armonía con la naturaleza han mantenido, controlado y preservado la quinua en su estado natural como alimentos para las generaciones actuales y las venideras” , agregó.

Considerado el “grano de oro de los Andes” , la quinua es un antiguo alimento de los indígenas andinos que integra actualmente dietas saludables en distintos rincones del mundo por sus excepcionales condiciones nutricionales, que han llevado a la NASA a incluirlo en los alimentación de los astronautas.

Según un estudio del gobierno boliviano la quinua es “el único alimento vegetal que posee todos los aminoácidos esenciales” , con un valor calórico “mayor al del huevo y la leche y comparable sólo al de la carne” y un contenido proteico que supera a granos como el trigo, arroz, maíz y avena.

Bolivia y Perú son los dos principales productores mundiales de quinua, aunque también se cultiva en Ecuador y Chile.